Vishnu Prasad Pulappadi, Krithika Rangarajan, Raja Pramanik, Mukesh K Yadav, Sanjay Thulkar
{"title":"Toxicity of anti-cancer drugs: the imaging findings to watch out for in common cancers.","authors":"Vishnu Prasad Pulappadi, Krithika Rangarajan, Raja Pramanik, Mukesh K Yadav, Sanjay Thulkar","doi":"10.1093/bjr/tqaf021","DOIUrl":null,"url":null,"abstract":"<p><p>A multitude of drugs are used for the treatment of various types of cancers. They consist of conventional cytotoxic agents and newer targeted agents. Both types of agents produce a variety of side effects by their effect on normal cells of the body. Regardless of whether they produce any symptoms or not, a proportion of these side effects can be visualised on imaging and their identification is crucial for guiding further management. While some of the adverse effects are mild and tolerable, many others require dose reduction and even withdrawal of the drug. A few of these manifestations may resemble tumour progression or recurrence on imaging. Therefore, appropriate knowledge regarding the imaging manifestations of the adverse effects caused by the chemotherapeutic agents used for various types of cancers is an integral part of onco-radiology practice. In this review, the common adverse effects of various anti-cancer drugs have been described based on the type of malignancy in which they occur, rather than based on the organ affected. This would allow the radiologist to look for common side effects while reading the scan of a patient with a specific cancer.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bjr/tqaf021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
A multitude of drugs are used for the treatment of various types of cancers. They consist of conventional cytotoxic agents and newer targeted agents. Both types of agents produce a variety of side effects by their effect on normal cells of the body. Regardless of whether they produce any symptoms or not, a proportion of these side effects can be visualised on imaging and their identification is crucial for guiding further management. While some of the adverse effects are mild and tolerable, many others require dose reduction and even withdrawal of the drug. A few of these manifestations may resemble tumour progression or recurrence on imaging. Therefore, appropriate knowledge regarding the imaging manifestations of the adverse effects caused by the chemotherapeutic agents used for various types of cancers is an integral part of onco-radiology practice. In this review, the common adverse effects of various anti-cancer drugs have been described based on the type of malignancy in which they occur, rather than based on the organ affected. This would allow the radiologist to look for common side effects while reading the scan of a patient with a specific cancer.
期刊介绍:
BJR is the international research journal of the British Institute of Radiology and is the oldest scientific journal in the field of radiology and related sciences.
Dating back to 1896, BJR’s history is radiology’s history, and the journal has featured some landmark papers such as the first description of Computed Tomography "Computerized transverse axial tomography" by Godfrey Hounsfield in 1973. A valuable historical resource, the complete BJR archive has been digitized from 1896.
Quick Facts:
- 2015 Impact Factor – 1.840
- Receipt to first decision – average of 6 weeks
- Acceptance to online publication – average of 3 weeks
- ISSN: 0007-1285
- eISSN: 1748-880X
Open Access option